Cataract Surgery In Patients With Advanced Age

October 24, 2019 updated by: Burçin Çakır, Sakarya University

Outcomes of Cataract Surgeries in Patients With Advanced Age

This study evaluates and compares clinical outcomes of < 85 and ≥ 85 year old patients who underwent cataract surgeries.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The medical records of patients who were underwent cataract surgery between January 2014 and October 2017 were investigated retrospectively and patients 65 years and older were recruited. Two groups were made according to age: group1 composed of patients age range between 65 and 85 years and group 2 composed of patients 85 years and older. Gender, presence of diabetes mellitus (DM), hypertension (HT), drug use were noted.

The results of best corrected visual acuity (BCVA) converted to LogMar, intraocular pressure (IOP) before and 3 months after operation, biomicroscopic and fundus examinations were investigated.

Additional ocular diseases such as glaucoma, age related macular degeneration (AMD), pseudoexfoliation syndrome, retinopathies and maculopathies related to systemic diseases were noted. Pupil dilation properties were also noted as poor, mid or full pupil dilation.

Cataract surgery techniques such as phacoemulsification, extra- and intracapsular lens extractions, peroperative complications, intracameral drug use were investigated.

these aforementioned outcomes evaluated and compared between groups.

Study Type

Observational

Enrollment (Actual)

152

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sakarya, Turkey
        • Sakarya University Ophthalmology Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 95 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients aged 65 years and older who underwent cataract surgery

Description

Inclusion Criteria:

  • patients aged 65 years and older patients who underwent cataract surgery

Exclusion Criteria:

  • patients aged below 65 years who underwent cataract surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group 1, patients aged 85 years and older
75 eyes of 75 patients (39 female, 36 male) Mean age: 86,8 ± 1,8 years
Cataract surgery was performed by using phacoemulsification technique, routinely. But other techniques for instance extra or intracapsular cataract extraction (ECCE, ICCE) techniques were performed when needed. Phacoemulsification technique was performed by 2 experienced surgeon (G.A. and E.C.) under topical anesthesia, thorough limbal incision. Foldable single piece hydrophobic acrylic intraocular lens (IOL) was inserted in the bag. In the presence of complications related to anterior or posterior capsules, 3 pieces IOL was preferred. When ECCE technique was chosen, single piece polymethyl methacrylate IOL was inserted.
Group 2, patients aged 65 and 85 years
77 eyes of 77 patients (34 female, 43 male) Mean age:73,3 ± 5,2 years
Cataract surgery was performed by using phacoemulsification technique, routinely. But other techniques for instance extra or intracapsular cataract extraction (ECCE, ICCE) techniques were performed when needed. Phacoemulsification technique was performed by 2 experienced surgeon (G.A. and E.C.) under topical anesthesia, thorough limbal incision. Foldable single piece hydrophobic acrylic intraocular lens (IOL) was inserted in the bag. In the presence of complications related to anterior or posterior capsules, 3 pieces IOL was preferred. When ECCE technique was chosen, single piece polymethyl methacrylate IOL was inserted.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Best corrected visual acuity
Time Frame: Before cataract surgery
Best corrected visual acuity converted to LogMar
Before cataract surgery
Best corrected visual acuity
Time Frame: three months after cataract surgery
Best corrected visual acuity converted to LogMar
three months after cataract surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
presence of Diabetes Mellitus
Time Frame: Baseline (Before cataract surgery)
number of participants who have diabetes mellitus
Baseline (Before cataract surgery)
presence of essential hypertension
Time Frame: before cataract surgery
number of participants who have essential hypertension
before cataract surgery
oral acetylsalicylic acid use
Time Frame: before cataract surgery
number of participants who have a history of acetylsalicylic acid use
before cataract surgery
oral flomax use
Time Frame: before cataract surgery
number of participants who have a history of oral flomax use
before cataract surgery
presence of age related macular degeneration
Time Frame: Baseline (Before cataract surgery)
number of participants who have age related macular degeneration
Baseline (Before cataract surgery)
presence of glaucoma
Time Frame: before cataract surgery
number of participants who have glaucoma
before cataract surgery
presence of pseudoexfoliation
Time Frame: before cataract surgery
number of participants who have pseudoexfoliation
before cataract surgery
presence of poor pupil dilation
Time Frame: During cataract surgery
number of participants who have poor pupil dilation
During cataract surgery
presence of zonule deficiency
Time Frame: During cataract surgery
number of participants who have zonule deficiency
During cataract surgery
Cataract types in patients who underwent cataract surgery
Time Frame: Baseline (Before cataract surgery)
number of participants who have nuclear, posterior subcapsular, corticonuclear, mature, nigra, traumatic cataract
Baseline (Before cataract surgery)
measurement of effective phacoemulsification time
Time Frame: During cataract surgery
measurement of effective phacoemulsification time in participants who underwent cataract surgery
During cataract surgery
presence of posterior capsule rupture
Time Frame: During cataract surgery
participants who had posterior capsule rupture during surgery
During cataract surgery
anterior vitrectomy
Time Frame: during surgery
number of participants who needed anterior vitrectomy during cataract surgery
during surgery
presence of aphakia
Time Frame: 3 months after cataract surgery
number of participants who left aphakic after cataract surgery
3 months after cataract surgery
intracameral adrenalin use
Time Frame: during surgery
number of participants who needed intracameral adrenalin use
during surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Burcin Cakir, MD, Sakarya University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 2, 2017

Primary Completion (Actual)

December 2, 2017

Study Completion (Actual)

February 25, 2018

Study Registration Dates

First Submitted

October 13, 2019

First Submitted That Met QC Criteria

October 24, 2019

First Posted (Actual)

October 25, 2019

Study Record Updates

Last Update Posted (Actual)

October 25, 2019

Last Update Submitted That Met QC Criteria

October 24, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Sakarya Ophthalmology

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Study Data/Documents

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract Senile

Clinical Trials on Cataract Surgery

3
Subscribe